PCN221 - The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability: Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours
| Autor: | Reck, M, Socinski, M, Szczesna, A, Dediu, M, Ramlau, R, Losonczy, G, Molinier, O, Schumann, C, Brown, J, Soldatenkova, V, Chouaki, N, Thatcher, N, Luft, A |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A748-A749 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect